Personalized allocation of acetylsalicylic acid therapy for secondary prevention of coronary artery disease.

Hegde, Nischal N; Mathew, Navin; Thachathodiyl, Rajesh; Menon, Jaideep C

Hegde, Nischal N; Mathew, Navin; Thachathodiyl, Rajesh; Menon, Jaideep C.

Afiliação

Hegde NN; Department of Cardiology, Amrita Institute of Medical Sciences, Kochi, India.
Mathew N; Department of Cardiology, Amrita Institute of Medical Sciences, Kochi, India.
Thachathodiyl R; Department of Cardiology, Amrita Institute of Medical Sciences, Kochi, India.
Menon JC; Department of Cardiology, Amrita Institute of Medical Sciences, Kochi, India.

Front Cardiovasc Med ; 9: 1004473, 2022.

Article em En | MEDLINE | ID: mdl-36237906

Palavras-chave

aspirin; aspirin regimen; aspirin resistance; coronary artery disease; secondary prevention ischemic heart disease; thromboxane B2

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google